Dr Reddy's Laboratories Ltd ADR (NYSE:RDY) - Share price - Overview

Stock Report

Dr Reddy's Laboratories Ltd RDY

Last Price
$35.87

Day Change
-0.93|-2.53%

As of 22/11/2017
16:11:04 EST | USD
Minimum 15 Minutes Delay.

Last Close36.80
Day Range35.65 - 36.43
Mkt Cap6.05Bil
52-Wk Range29.83 - 47.75
Yield %0.88
ISINUS2561352038
Volume346,639
P/E-
P/S2.73
P/CF20.88

Share Price

Financials
201520162017
More ...
Income Statement
Revenue148,189.00154,708.00140,809.00
Operating Income26,286.0029,619.0013,498.00
Net Income22,179.0020,013.0012,039.00
Basic EPS130.22117.3472.24
Avg. Diluted Shares Outstanding171171167
Balance Sheet
Current Assets119,838.00119,688.00100,375.00
Non Current Assets74,924.0087,962.00119,446.00
Total Assets194,762.00207,650.00219,821.00
Current Liabilities63,995.0064,646.0085,000.00
Total Liabilities83,460.0079,314.0095,777.00
Total Equity111,302.00128,336.00124,044.00
Cash Flow
Operating Cash Flow25,033.0041,247.0021,513.00
Capital Expenditure-15,327.00-14,875.00-40,984.00
Free Cash Flow9,706.0026,372.00-19,471.00

In millions, except "Basic EPS". Currency is INR.

Company Profile

Dr Reddy's Laboratories Ltd is associated with the healthcare sector. Its core business includes the manufacturing of pharmaceutical products.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Growth

Fiscal Year Ends

March

Employees

22,671
Key Stats
More ...
Price/Earning TTM-
Price/Book3.24
Price/Sales TTM-
Rev Growth (3 year avg)2.13
EPS Growth (3 year avg)-
Operating Margin % TTM9.59
Net Margin % TTM8.55
ROE TTM9.54
Debt/Equity0.04
Dividends
PreviousLatest
More ...
Declared Date03/06/1606/06/17
Ex-Div14/07/1613/07/17
Paid09/08/1610/08/17
Amnt0.300.31
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.